- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.02 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 6 residues within 4Å:- Chain A: H.127, V.130, E.132, K.149, K.171, N.173
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 10 residues within 4Å:- Chain A: D.311, N.340, T.343, N.592, D.593, L.595
- Chain C: R.502, Y.513, D.514, P.515
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:D.514
- Hydrogen bonds: C:R.502, C:Y.513
NAG-NAG.4: 4 residues within 4Å:- Chain A: S.630, V.649, T.650, N.651
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 8 residues within 4Å:- Chain A: T.603, D.604, V.605, C.606, I.619, Y.686, N.689, N.690
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.603
NAG-NAG.6: 5 residues within 4Å:- Chain A: F.699, D.700, N.711, T.713, D.714
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 6 residues within 4Å:- Chain B: H.127, V.130, E.132, K.149, K.171, N.173
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 10 residues within 4Å:- Chain A: Y.513, D.514, P.515, R.516
- Chain B: D.311, N.340, T.343, N.592, D.593, L.595
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:D.514
- Hydrogen bonds: A:Y.513
NAG-NAG.11: 5 residues within 4Å:- Chain B: S.630, K.646, V.649, T.650, N.651
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 8 residues within 4Å:- Chain B: T.603, D.604, V.605, C.606, I.619, Y.686, N.689, N.690
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 5 residues within 4Å:- Chain B: F.699, D.700, N.711, T.713, D.714
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 7 residues within 4Å:- Chain C: H.127, V.130, E.132, K.149, K.171, K.172, N.173
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 10 residues within 4Å:- Chain B: Y.513, D.514, P.515, R.516
- Chain C: D.311, N.340, T.343, N.592, D.593, L.595
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.514, B:D.514
NAG-NAG.18: 3 residues within 4Å:- Chain C: V.649, T.650, N.651
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 8 residues within 4Å:- Chain C: T.603, D.604, V.605, C.606, I.619, Y.686, N.689, N.690
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:T.603
NAG-NAG.20: 5 residues within 4Å:- Chain C: F.699, D.700, N.711, T.713, D.714
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.7: 7 residues within 4Å:- Chain A: V.1199, N.1200
- Chain B: D.867, V.868, D.869, N.870, Q.990
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.867, B:D.867, B:D.867, B:N.870
NAG-NAG-BMA.14: 7 residues within 4Å:- Chain B: V.1199, N.1200
- Chain C: D.867, V.868, D.869, N.870, Q.990
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:D.867, C:D.867, C:D.867, C:N.870
NAG-NAG-BMA.21: 7 residues within 4Å:- Chain A: D.867, V.868, D.869, N.870, Q.990
- Chain C: V.1199, N.1200
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.867, A:D.867, A:N.870
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 5 residues within 4Å:- Chain A: N.6, N.9, E.142
- Chain C: I.482
- Ligands: NAG-NAG-BMA-MAN-MAN.1
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.43, N.257
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: F.10, S.154, R.155, N.156
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.177, S.179, T.180
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain A: S.232, N.233, T.234, D.235, N.236
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: F.321, P.415, I.417, N.418
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.439
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain A: N.455, T.457, S.519
- Chain B: K.77, D.82
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain A: S.547, N.549, V.550
- Ligands: NAG-NAG-BMA-MAN-MAN.8
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: S.718, P.758, N.760
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.765, K.778
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.782, I.1140
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain A: K.901, E.909, A.910, N.913
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain A: I.482
- Chain B: N.6, N.9, E.142
- Ligands: NAG-NAG-BMA-MAN-MAN.8
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.43, N.257
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: F.10, S.154, R.155, N.156
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: N.177, S.179, T.180
Ligand excluded by PLIPNAG.40: 5 residues within 4Å:- Chain B: S.232, N.233, T.234, D.235, N.236
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain B: F.321, P.415, I.417, N.418
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.439
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain B: N.455, T.457, S.519
- Chain C: D.82
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain B: S.547, N.549, V.550
- Ligands: NAG-NAG-BMA-MAN-MAN.15
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: S.718, P.758, N.760
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.765
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: N.782, I.1140
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain B: K.901, E.909, A.910, N.913
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN.15
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: N.43, N.257
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain C: F.10, S.154, R.155, N.156
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: N.177, S.179, T.180
Ligand excluded by PLIPNAG.54: 6 residues within 4Å:- Chain C: S.231, S.232, N.233, T.234, D.235, N.236
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain C: F.321, I.417, N.418
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain C: N.439
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain A: D.82
- Chain C: N.455, T.457, S.519
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain C: S.547, N.549, V.550
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain C: S.718, P.758, N.760
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain C: N.765, K.778
Ligand excluded by PLIPNAG.61: 2 residues within 4Å:- Chain C: N.782, I.1140
Ligand excluded by PLIPNAG.62: 4 residues within 4Å:- Chain C: K.901, E.909, A.910, N.913
Ligand excluded by PLIP- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
01.35: 18 residues within 4Å:- Chain A: N.13, L.15, T.17, T.18, L.64, K.65, G.66, T.67, Y.69, L.70, S.71, W.74, C.227, N.228, A.229, S.231, N.233, T.234
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:T.17, A:L.64, A:Y.69, A:W.74, A:T.234
- Hydrogen bonds: A:N.13, A:T.17, A:T.17, A:K.65, A:K.65, A:T.67, A:T.67, A:T.67, A:N.233
- Salt bridges: A:K.65
01.49: 18 residues within 4Å:- Chain B: N.13, L.15, T.17, T.18, L.64, K.65, G.66, T.67, Y.69, L.70, S.71, W.74, C.227, N.228, A.229, S.231, N.233, T.234
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:T.17, B:L.64, B:Y.69, B:W.74
- Hydrogen bonds: B:N.13, B:T.17, B:T.17, B:K.65, B:K.65, B:T.67, B:T.67, B:T.67, B:T.67, B:S.231, B:N.233
- Salt bridges: B:K.65
01.63: 17 residues within 4Å:- Chain C: N.13, L.15, T.17, T.18, L.64, K.65, G.66, T.67, Y.69, L.70, S.71, W.74, N.228, A.229, S.231, N.233, T.234
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:T.17, C:L.64, C:Y.69, C:W.74, C:T.234
- Hydrogen bonds: C:N.13, C:T.17, C:T.17, C:K.65, C:K.65, C:T.67, C:T.67, C:T.67, C:T.67, C:N.233
- Salt bridges: C:K.65
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
BC
A
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.02 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
BC
A